Literature DB >> 23526458

Survival in dementia and predictors of mortality: a review.

Stephen Todd1, Stephen Barr, Mark Roberts, A Peter Passmore.   

Abstract

OBJECTIVE: Dementia is an important cause of mortality and, with the ageing population and increasing prevalence of dementia, reliable data on prognosis and survival will be of interest to patients and caregivers as well as providers and commissioners of health and social care. A review of the literature was undertaken to determine the rates of survival in dementia and Alzheimer's disease (AD) and to identify factors that are or are not predictive of mortality in dementia and AD.
METHODS: Relevant articles on mortality in dementia were identified following a search of several electronic databases from 1990 to September 2012. Inclusion criteria were reports on prospective community or clinic based cohorts published in English since 1990, to reflect more recent recognition of possible predictors.
RESULTS: Median survival time from age of onset of dementia ranges from 3.3 to 11.7 years, with most studies in the 7 to 10-year period. Median survival time from age of disease diagnosis ranges from 3.2 to 6.6 years for dementia or AD cohorts as a whole. Age was consistently reported as a predictor of mortality, with male gender a less consistent predictor. Increased disease severity and functional impairment were often associated with mortality.
CONCLUSIONS: Substantial heterogeneity in the design of included studies limits the ability to prognosticate for individual patients. However, it is clear that dementia and AD are associated with significant mortality. Reasons for the increased mortality are not established.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Alzheimer's disease; dementia; mortality; survival

Mesh:

Year:  2013        PMID: 23526458     DOI: 10.1002/gps.3946

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  104 in total

1.  Postmortem Brain, Cerebrospinal Fluid, and Blood Neurotrophic Factor Levels in Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Authors:  Yang Du; Huan-Tong Wu; Xiao-Yan Qin; Chang Cao; Yi Liu; Zong-Ze Cao; Yong Cheng
Journal:  J Mol Neurosci       Date:  2018-06-28       Impact factor: 3.444

Review 2.  The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer's Disease Cohorts.

Authors:  Amy L Heffernan; Cameron Chidgey; Po Peng; Colin L Masters; Blaine R Roberts
Journal:  J Mol Neurosci       Date:  2016-08-06       Impact factor: 3.444

3.  Development and testing of a decision aid on goals of care for advanced dementia.

Authors:  Seth F Einterz; Robin Gilliam; Feng Chang Lin; J Marvin McBride; Laura C Hanson
Journal:  J Am Med Dir Assoc       Date:  2014-02-06       Impact factor: 4.669

Review 4.  Epigenetics in Alzheimer's Disease: Perspective of DNA Methylation.

Authors:  Talal Jamil Qazi; Zhenzhen Quan; Asif Mir; Hong Qing
Journal:  Mol Neurobiol       Date:  2017-01-14       Impact factor: 5.590

5.  Advanced Dementia.

Authors:  Susan L Mitchell
Journal:  N Engl J Med       Date:  2015-09-24       Impact factor: 91.245

6.  Incident depression and mortality among people with different types of dementia: results from a longitudinal cohort study.

Authors:  Laura Perna; H W Wahl; J Weberpals; L Jansen; U Mons; B Schöttker; H Brenner
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-03-06       Impact factor: 4.328

Review 7.  CLINICAL PRACTICE. Advanced Dementia.

Authors:  Susan L Mitchell
Journal:  N Engl J Med       Date:  2015-06-25       Impact factor: 91.245

Review 8.  Alzheimer's Disease Therapeutic Approaches.

Authors:  Maria Revi
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

9.  U.S. National Profile of Older Adults with Cognitive Impairment Alone, Physical Frailty Alone, and Both.

Authors:  Mei-Ling Ge; Michelle C Carlson; Karen Bandeen-Roche; Nadia M Chu; Jing Tian; Judith D Kasper; Qian-Li Xue
Journal:  J Am Geriatr Soc       Date:  2020-08-28       Impact factor: 5.562

10.  Left Ventricular Hypertrophy and Remodeling and Risk of Cognitive Impairment and Dementia: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Kasra Moazzami; Mohammad Reza Ostovaneh; Bharath Ambale Venkatesh; Mohammadali Habibi; Kihei Yoneyama; Colin Wu; Kiang Liu; Isabel Pimenta; Annette Fitzpatrick; Steven Shea; Robyn L McClelland; Susan Heckbert; Rebecca F Gottesman; David A Bluemke; Timothy M Hughes; João A C Lima
Journal:  Hypertension       Date:  2018-01-29       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.